Valuation: Johnson & Johnson

Capitalization 560B 485B 445B 419B 780B 53,396B 792B 5,292B 2,060B 25,823B 2,104B 2,058B 89,800B P/E ratio 2026 *
24.9x
P/E ratio 2027 * 22.6x
Enterprise value 579B 501B 460B 433B 806B 55,152B 818B 5,466B 2,127B 26,672B 2,173B 2,126B 92,754B EV / Sales 2026 *
5.74x
EV / Sales 2027 * 5.3x
Free-Float
77.1%
Yield 2026 *
2.29%
Yield 2027 * 2.39%
1 day+2.02%
1 week+3.30%
Current month+3.30%
1 month+3.63%
3 months-3.17%
6 months+15.27%
Current year+12.48%
1 week 220.84
Extreme 220.84
235.22
1 month 220.37
Extreme 220.37
235.5
Current year 200.91
Extreme 200.9101
251.71
1 year 149.04
Extreme 149.04
251.71
3 years 140.68
Extreme 140.68
251.71
5 years 140.68
Extreme 140.68
251.71
10 years 109.16
Extreme 109.16
251.71
Manager TitleAgeSince
Chief Executive Officer 63 03/01/2022
Director of Finance/CFO 59 01/07/2018
Chief Tech/Sci/R&D Officer 60 05/11/2019
Director TitleAgeSince
Director/Board Member 62 15/10/2013
Director/Board Member 71 09/06/2015
Chairman 63 02/01/2023
Date Insider Type Main position Quantity % Market Cap.
05-01Fiscal year

Executive/Senior Manager

61,512 0.0026%
04-23Free

Director

975 0.0000%
04-23Free

Director

1,712 0.0001%
Change 5d. change 1-year change 3-years change Capi.($)
+2.02%+3.30%+50.15%+47.16% 560B
+0.55%+2.39%+46.96%+155.36% 1,009B
+1.02%+4.37%+19.70%+67.78% 401B
+0.77%-0.67%+21.96%+11.96% 328B
+2.24%+0.41%+28.53%+17.12% 288B
+1.85%+0.14%+21.53%+30.34% 272B
+4.43%-3.11%-42.11%-49.56% 194B
+1.15%+3.80%+20.41%+58.02% 189B
-0.02%-3.92%+14.85%+69.50% 160B
+1.36%-0.53%+11.52%-32.13% 148B
Average +1.54%+0.97%+19.35%+37.55% 355B
Weighted average by Cap. +1.34%+1.84%+29.41%+66.24%

Financials

2026 *2027 *
Net sales 101B 87.37B 80.17B 75.43B 140B 9,614B 143B 953B 371B 4,650B 379B 371B 16,169B 107B 92.9B 85.24B 80.2B 149B 10,223B 152B 1,013B 394B 4,944B 403B 394B 17,192B
Net income 22.05B 19.1B 17.52B 16.49B 30.71B 2,101B 31.19B 208B 81.06B 1,016B 82.8B 81B 3,534B 24.34B 21.08B 19.34B 18.2B 33.9B 2,320B 34.43B 230B 89.49B 1,122B 91.41B 89.42B 3,902B
Net Debt 18.44B 15.97B 14.65B 13.78B 25.67B 1,757B 26.07B 174B 67.77B 850B 69.22B 67.72B 2,955B 8.04B 6.96B 6.39B 6.01B 11.19B 766B 11.37B 75.93B 29.55B 370B 30.19B 29.53B 1,288B
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2025, Johnson & Johnson has 63 manufacturing facilities located in the United States (22), North America (7), Europe (22), Africa and Asia/Pacific (12). The United States accounts for 57.1% of net sales.
Employees
138,200
Date Price Change Volume
05/06/26 232.77 $ +2.02% 8,034,922
04/06/26 228.17 $ +2.21% 7,274,807
03/06/26 223.24 $ +0.16% 6,507,220
02/06/26 222.89 $ -0.28% 5,668,958
01/06/26 223.51 $ -0.81% 8,040,997
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
232.77USD
Average target price
252.87USD
Spread / Average Target
+8.63%

Quarterly revenue - Rate of surprise